Company Overview - MedWell Ai, Inc has signed a Letter of Intent to establish a vertically integrated health, wellness, and longevity platform [1] - The new structure will consist of three core divisions: national pharma distribution and telemed platform, a portfolio of surgical and cosmetic centers, and an advanced biologics and product innovation group [2] Acquisitions and Financial Projections - The company plans to acquire and consolidate several entities, including Ageless Cosmetic Surgery Centers, Apollo BioWellness, and MedWell USA, which is currently generating revenues of $14 million in 2025 [3] - The consolidated company is projected to exceed $25 million in annual revenues for 2026, with conservative EBITDA margins of at least 20% [3] Strategic Goals and Management - The CEO of MedWell Ai emphasizes the goal of creating a comprehensive wellness ecosystem to enhance supply chain efficiency, quality control, and national expansion [5] - The company is also looking to bring in a seasoned management team to oversee the three verticals and is considering additional strategic acquisitions [5] Market Insights - The global regenerative medicine market was valued at approximately USD 35.5 billion in 2024 and is expected to grow to over USD 169 billion by 2034, with a CAGR of roughly 16% to 23% [7] - The broader global wellness economy reached USD 6.3 trillion in 2023 and is forecasted to reach USD 9.8 trillion by 2029 [7] - North America holds over 58% of the global market share in regenerative medicine, with the U.S. market projected to surpass USD 80 billion by 2033 [7]

Core Insights - Apollo Biowellness, Inc. has signed a Letter of Intent to establish a vertically integrated health, wellness, and longevity platform [1] - New MedWell Ai, Inc. will operate across three divisions: national pharma distribution and telemedicine, surgical and cosmetic centers, and advanced biologics [3] - The consolidated company is projected to exceed $25 million in annual revenues for 2026, based on trailing revenues of $14 million in 2025, with conservative EBITDA margins of at least 20% [4] Company Developments - The CEO of MedWell Ai, Steve Rubakh, emphasized the creation of a comprehensive wellness ecosystem aimed at reducing supply chain inefficiencies and enabling national expansion [5] - The company is also considering additional strategic acquisitions to enhance its position in the regenerative wellness sector [5] Market Overview - The global regenerative medicine market was valued at approximately $35.5 billion in 2024 and is expected to reach over $169 billion by 2034, growing at a CAGR of roughly 16% to 23% [8] - The broader global wellness economy reached $6.3 trillion in 2023 and is forecasted to grow to $9.8 trillion by 2029 [8] - North America is the leading market, accounting for over 58% of the global market share in 2024, with the U.S. market projected to surpass $80 billion by 2033 [8]